AIGEN INVESTMENT MANAGEMENT, LP - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 87 filers reported holding UROGEN PHARMA LTD in Q4 2019. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
AIGEN INVESTMENT MANAGEMENT, LP ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2020$207,000
-26.3%
10,712
-0.4%
0.03%
-27.8%
Q2 2020$281,000
+84.9%
10,750
+26.4%
0.04%
+80.0%
Q1 2020$152,000
+270.7%
8,506
+592.7%
0.02%
+185.7%
Q4 2019$41,0001,2280.01%
Other shareholders
UROGEN PHARMA LTD shareholders Q4 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,620,545$36,713,8356.69%
Wildcat Capital Management, LLC 495,606$6,943,4402.79%
SILVERARC CAPITAL MANAGEMENT, LLC 508,883$7,129,4512.16%
Opaleye Management Inc. 320,000$4,483,2001.46%
AlphaCentric Advisors LLC 165,000$2,311,6501.31%
Soleus Capital Management, L.P. 372,000$5,211,7200.48%
EAM Investors, LLC 170,523$2,389,0270.46%
RA Capital Management 1,483,697$20,786,5950.41%
Parkman Healthcare Partners LLC 145,311$2,035,8070.37%
MENORA MIVTACHIM HOLDINGS LTD. 2,303,031$32,265,4640.29%
View complete list of UROGEN PHARMA LTD shareholders